FLFrançois-Xavier Lescure

François-Xavier Lescure

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


François-Xavier Lescure has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2007
      • Vol. 11  (1) , 78-84

    Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment.

    by E Pukenyte, F X Lescure, D Rey, C Rabaud, B Hoen, P Chavanet, A P Laiskonis, J L Schmit, T May, Y Mouton, et al.

    To assess the incidence and risk factors for severe liver toxicity in human immunodeficiency virus (HIV) infected patients on anti-tuberculosis treatment and the impact of patients' characteristics and concomitant medications instituted during the first week of antituberculosis treatment. HIV-infected patients referred to six French hospitals between 1 January 1992 and 31 December 2004, with confirmed or 'presumptive' tuberculosis (TB). Liver toxicity was studied during the first 2 months of TB treatment. During the 12 years of the study period, 144 patients were enrolled. Severe liver toxicity developed in 15 (10.7%). The median time to development of liver toxicity was 14 days. In the univariate analysis, high baseline bilirubin levels (P = 0.004), CD4 cell counts between 50 and 100 cells/mm3 (P = 0.022) and the use of fluconazole (P = 0.0005) were associated with liver toxicity. In the multivariate analysis, independent risk factors were abnormal baseline alanine aminotransferase (ALT) (P = 0.028) and bilirubin levels (P = 0.033) and the use of fluconazole (P = 0.008). Severe liver toxicity is frequent, and occurs early in the course of anti-tuberculosis treatment. ALT and bilirubin levels should be closely monitored during the first month of treatment, especially in patients with high baseline ALT or bilirubin levels. We suggest caution when prescribing fluconazole and anti-tuberculosis drugs concomitantly, although this needs to be confirmed and further investigated.


  • Open Access

    Increased Prevalence of Hypothyroidism among Human Immunodeficiency Virus—Infected Patients: A Need for Screening

    by Sonia Beltran, François-Xavier Lescure, Rachel Desailloud, Youcef Douadi, Amar Smail, Isabelle El Esper, Sylvie Arlot, Jean-Luc Schmit, Thyroid and VIH (THYVI) Group

    The aim of this cross-sectional multicenter study was to determine the prevalence of and risk factors for hypothyroidism in human immunodeficiency vi


    • 16 February 2002
      • Vol. 31  (6) , 259-61

    [Atypical cutaneous leishmaniasis].

    by F X Lescure, P Bonnard, J Chandenier, J L Schmit, Y Douadi

    French Guyana is an endemic area for American cutaneous leishmaniasis. At the start, the initial red lesion may be mistaken for a whitlow. Twenty percent of developed forms exhibit a sporotrichosis pattern. The notion of travel to an endemic area is very important for diagnosis. We report the case of a young man from French Guyana presenting with a cutaneous lesion of the finger. After numerous surgical treatments for a "whitlow", the final diagnosis of leishmaniasis was difficult because of local-complications and cutaneous rearrangement. Erroneous initial orientation in a unit unaware of tropical diseases can forestall appropriate care of the patients. Epidemiological, clinical and therapeutic data on American tegument leishmaniasis are discussed.